U.S. Medical Aesthetic Devices Market Size, Share, and Trends 2024 to 2034

The U.S. medical aesthetic devices market size was USD 5.57 billion in 2023, estimated at USD 6.16 billion in 2024 and is anticipated to reach around USD 16.31 billion by 2034, expanding at a CAGR of 10% from 2024 to 2034.

  • Last Updated : 04 Sep 2024
  • Report Code : 2483
  • Category : Healthcare

U.S. Medical Aesthetic Devices Market Size and Forecast  2024 to 2034

The U.S. medical aesthetic devices market size is estimated at USD 6.16 billion in 2024 and is predited to surpass around USD 16.31 billion by 2034, growing at a CAGR of 10% from 2024 to 2034.

U.S. Medical Aesthetic Devices Market Size 2024 To 2034

Key Takeaways

  • On the basis of type of device, the non-energy-based aesthetic device segment accounted for 79.40% of revenue share in 2023.
  • On the basis of application, the skin resurfacing and tightening segment held the highest market share in 2023.
  • On the basis of end-user, the hospitals and clinics segment accounted for the biggest market share in 2023.

U.S. Medical Aesthetic Devices Market Overview

Medical Aesthetic Devices are used to overcome flaws in a person's physical appearance. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) estimates that in the United States in 2021, 1.4 million surgical and non-surgical operations were carried out. The top 5 cosmetic surgical procedure in the United States includes Facelift surgeries, Liposuction, Breast Augmentation, Nose reshaping, and eyelid surgery. The demand for aesthetic treatment in developing countries is growing due to the urge to look young and fit. 

The aesthetic method such as liposuction, nose reshaping, and Botox injection are gaining consumer attention. Skin-tightening and non-invasive fat technologies have recently established out a new niche in the medical aesthetics market. The key factors enhancing the growth of the U.S. Aesthetic Medical Device market are a surge in the prevalence of facial deformities and congenital teeth, enhancement in demand for non-invasive surgeries, an increase in the number of cosmetic surgeries, and advancement in aesthetic devices.

COVID -19 Impact:

Manufacturers of cosmetic and aesthetic devices were ordered to cease manufacturing and supply because of the global lockdown that was implemented at the start of the COVID-19 pandemic. The pandemic had a significant impact on both invasive and non-invasive aesthetic operations, including the market for body contouring. For instance, according to Bloomberg, non-invasive fat removal, injectable lipolysis, invasive liposuction soft tissue fillers, facelifts, eye lifts, eyelid operations, laser skin resurfacing, rhinoplasty, and tummy tucks, saw a 20% decline in first half of 2020. However, according to The International Society of Aesthetic Plastic Surgery, by the end of 2020, the desire and demand for aesthetic procedures like body contouring had dramatically grown and had surpassed pre-pandemic levels.

US Medical Aesthetic Devices Market Scope

Report Coverage Details
Market Size in 2023 USD 5.57 Billion
Market Size in 2024 USD 6.16 Billion
Market Size by 2034 USD 16.31 Billion
Growth Rate from 2024 to 2034 CAGR of 9.75%
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered By Type of Device, By Application, By End User


Market Dynamics 

Drivers

The rising prevalence of obesity, increased awareness of cosmetic treatments, expanding use of minimally invasive devices, and technical developments in devices are some factors that are fueling the market's growth.

The rise in the choice of minimally invasive and non-invasive cosmetic surgeries

  • Compared to standard surgical treatments, minimally invasive/nonsurgical methods provide a variety of benefits, such as quicker recovery times and less pain and scarring. For instance, according to the American Society of Plastic Surgeons, Plastic Surgery Statistics Report 2020, there were 6.8 million reconstructive procedures, 13.2 million cosmetic minimally invasive procedures, and 2.3 million cosmetic surgical procedures performed in the United States in 2020.

High Awareness of cosmetic operations and rising obesity rates

  • A person's appearance can be improved without surgery using medical aesthetic devices. These goods, which also use the name "cosmetic surgery devices," include a wide range of things including laser hair removal equipment, microdermabrasion equipment, photo rejuvenation systems, cellulite reduction equipment, body contouring equipment, breast implants, and others. Although the geriatric population is mostly driving the need for aesthetic operations, younger people are also favoring the usage of aesthetic procedures, which is driving the demand for aesthetic equipment. 
  • WHO estimates that the prevalence of obesity has risen since 1975 and that roughly 30% of people worldwide are obese. A primary underlying cause of obesity, illness, and disability is sedentary behavior. All developed and emerging nations have high levels of physical inactivity.

Restraints

High cost and side effects of the aesthetic surgery device

  • The risk of potential side effects comes along with technological innovation in various cosmetic procedures. A few commonly occurring side effects in patients undergoing breast augmentation or facelift includes hematoma. Another side effect that occurs after a tummy tuck or body fat reduction is seroma, which appears in 15-30% of patients. Despite several therapeutic and aesthetic applications of botox, the expense and side effects are expected to hinder the market growth. 

Opportunities:

Accessibility to technologically advanced and user-friendly products

  • Non-invasive fat-freezing body contouring system has led to technologically improved products. The market for medical aesthetic devices will be boosted by rising investments in research and development for the launch of new products. For instance, Cynosure introduced the Elite iQ platform in the US, European, and Australian markets in June 2020 for laser hair removal and skin rejuvenation applications.

The breast implants sub-segment is Expected to show rapid grow in the implants segment of the market

  • The International Society of Aesthetic Plastic Surgery Report 2020 states that 371,997 breast augmentation operations were performed in the US in 2016. The market is anticipated to grow at a modest rate over the projected period as a result of its prevalence among celebrities and anyone seeking to enhance their outer appearance. 

Type Insights

The devices segment dominated the market in 2023, accounting for the largest market share. The increasing demand for non-invasive aesthetic surgeries significantly boosted the demand for medical aesthetic devices. Laser and radiofrequency devices are increasingly used in aesthetic procedures to remove hair, tighten skin, reduce wrinkles, and stimulate collagen production, which further promotes skin rejuvenation. The increasing investments in R&D to develop sophisticated aesthetic devices further contributed to the segment’s growth. Moreover, the increased number of laser-based aesthetic procedures performed in the last few years bolstered the segment. 

The aesthetic implants segment is anticipated to expand at the fastest growth rate during the forecast period due to the rising demand for body contouring procedures. Aesthetic implants, including buttocks and breast implants, are widely used in body contouring procedures to enhance the specific part of the body. Moreover, the increasing popularity of breast augmentation surgery fuels the segment. For instance,

  • In 2021, about 365,000 breast augmentation procedures were performed in the US, up 44% from 2021.

Application Insights

The non-surgical segment led the market in 2023 and is expected to continue its dominance throughout the projection period due to the increasing number of non-surgical aesthetic procedures performed in the US. The segment growth is attributed to the easy availability and accessibility of non-surgical procedures in medical spas and beauty centers. Non-surgical aesthetic procedures often require less time than surgical procedures, appealing individuals seeking aesthetic enhancement. Moreover, the growing awareness about the benefits of non-surgical procedures is expected to boost the segment.

End-User Insights

The hospitals and clinics segment held a large share of the market in 2023 due to the availability of advanced aesthetic devices in hospital settings. The easy accessibility to these devices and the availability of skilled professionals encourage individuals to perform aesthetic surgeries in hospital settings under physician consultation. Moreover, the rapid expansion of derma clinics contributed to the segmental growth.

U.S. Medical Aesthetic Devices Market Companies

  • Cynosure 
  • Alma Lasers
  • Lumenis Inc.
  • Bausch Health Companies Inc. (Solta Medical Inc.) 
  • Abbvie
  • Lumenis Ltd.
  • Dentsply Sirona, Inc.
  • Dentsply Sirona, Inc.
  • PhotoMedex, Inc.
  • Straumann

Recent Developments

  • In June 2022, Cynosure launches the PicoSure Pro device, a next-generation aesthetic laser device. PicoSure Pro is the first and only 755nm picosecond laser that has received FDA clearance. It uses pressure rather than heat to deliver energy in a trillionth of a second, offering all skin types safe and effective treatments for hyperpigmentation and skin rejuvenation. 
  • In November 2021, an agreement was signed between NanoPass Technologies and Aesthetic Management Partners (AMP) to commercialize NanoPass’s MicronJet 600 intradermal delivery device in the United States.
  • In May 2021, Soliton, a medical device firm, is acquired by Allergen Aesthetics. Due to the acquisition, Allergan have access to Soliton's RESONIC rapid acoustic pulse (RAP) technology. RESONIC got the US Food and Drug Administration's 510(k) certification. It is a non-invasive gadget designed to temporarily improve cellulite appearance.
  • In March 2021, Longer-lasting neuromodulator drug candidate DaxibotulinumtoxinA for Injection (DAXI), a Botulinum Toxin Type A formulated with a novel peptide excipient or combined treatment of glabellar, dynamic forehead, and lateral canthal lines was introduced by Revance Therapeutics, Inc. 
  • In August 2020, NuEra Tight with FocalRF technology has been invented by Lumenis Ltd., the leading energy-based medical device business for cosmetic, surgical, and ophthalmic purposes.

Segments Covered in the Report

By Type

  • Devices
    • Energy-based Aesthetic Device
    • Laser-based Aesthetic Device
    • Radiofrequency (RF)-based Aesthetic Device
    • Light-based Aesthetic Device
    • Ultrasound Aesthetic Device
    • Non-energy-based Aesthetic Device
    • Botulinum Toxin
    • Dermal Fillers and Aesthetic Threads
    • Microdermabrasion
    • Others
  • Aesthetic Implants
    • Facial Implants
    • Breast Implants
    • Others

By Application

  • Surgical
  • Non-surgical

By End-user

  • Hospitals and Clinics
  • Medical Spas and Beauty Centers

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The US medical aesthetic devices market size was accounted at USD 5.57 billion in 2023 and it is expected to reach around USD 16.31 billion by 2034.

The US medical aesthetic devices market is poised to grow at a CAGR of 10% from 2024 to 2034.

The major players operating in the US medical aesthetic devices market are Cynosure, Alma Lasers, Lumenis Inc., Bausch Health Companies Inc. (Solta Medical Inc.), Abbvie, Lumenis Ltd., Dentsply Sirona, Inc., Dentsply Sirona, Inc., PhotoMedex, Inc., Straumann and Others.

The driving factors of the US medical aesthetic devices market are the rise in the choice of minimally invasive and non-invasive cosmetic surgeries, High Awareness of cosmetic operations and rising obesity rates.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Sanket Gokhale is one of the key authors contributing to the high-quality, actionable insights that define our market research reports. Sanket holds an MBA with a specialization in Healthcare Management, coupled with a Bachelor’s degree in Pharmacy. With over 5 years of experience in market research, Sanket has cultivated a deep understanding of the healthcare sector, from pharmaceutical innovations to healthcare

Learn more about Sanket Gokhale

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports